About this resource
Publication date:
Publication type:
Guideline
Language:
English
Australian Government Department of Health, Disability and Ageing
Life Saving Drugs Program – Acid sphingomyelinase deficiency (ASMD) types A/B and B – Guidelines
These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for acid sphingomyelinase deficiency (ASMD) types A/B and B under the Life Saving Drugs Program.